On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationThe World Allergy Organization journal
View this publicationScientific reports
View this publicationScientific reports
View this publicationScience translational medicine
View this publicationSTAR protocols
View this publicationInternational journal of stroke : official journal of the International Stroke Society
View this publicationAnnals of surgical oncology
View this publicationScientific reports
View this publicationInterdisciplinary cardiovascular and thoracic surgery
View this publication